Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Park Hyung Soon; Lim Sun Min; Shin Ho Jung; Cho Arthur; Shin Jae-Gook; Lee Min Goo; Kim Hye Ryun; Kim Joo Hang; Cho Byoung Chul

首页> 外文期刊>Pharmacogenetics and genomics >Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

【24h】

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

机译：一线紫杉醇联合卡铂化疗治疗晚期非小细胞肺癌的药物遗传学分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background

机译：背景

著录项

来源
《Pharmacogenetics and genomics》 |2016年第3期|共10页
作者
Park Hyung Soon; Lim Sun Min; Shin Ho Jung; Cho Arthur; Shin Jae-Gook; Lee Min Goo; Kim Hye Ryun; Kim Joo Hang; Cho Byoung Chul;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
paclitaxel; SLCO1B3; polymorphism; toxicity; survival; non-small-cell lung cancer;

机译：紫杉醇;SLCO1B3;多态性;毒性;生存率;非小细胞肺癌;

相似文献

外文文献
中文文献
专利

1. Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy [J] . Park Hyung Soon, Lim Sun Min, Shin Ho Jung, Pharmacogenetics and genomics . 2016,第3期

机译：一线紫杉醇联合卡铂化疗治疗晚期非小细胞肺癌的药物遗传学分析
2. Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network. [J] . Hainsworth JD, Gray JR, Morrissey LH, Journal of Clinical Oncology . 2002,第13期

机译：对以紫杉醇/卡铂为基础的化疗方案治疗晚期非小细胞肺癌患者的长期随访：Minnie Pearl癌症研究网络的连续II期临床试验。
3. Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes [J] . Hirsh Vera, Ko Amy, Pilot Richard, Clinical lung cancer . 2016,第5期

机译：每周nab-紫杉醇联合卡铂作为晚期非小细胞肺癌患者的一线治疗：糖尿病患者的安全性和有效性分析
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599 [O] . Julie R. Brahmer, Suzanne E. Dahlberg, Robert J. Gray, -1

机译：贝伐单抗治疗结果的性差异：患有或不含Bevacizumab的晚期非小细胞肺癌患者的分析与紫杉醇和卡铂联合在东方合作肿瘤学群试验4599中
7. Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis [O] . A. Ardizzoni, L. Boni, M. Tiseo, 2007

机译：顺铂 - 基于卡铂的高级小细胞肺癌一线治疗的化疗：个体患者数据META分析

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅